Summary

● Overall, the company has poor fundamentals for a medium to long-term investment strategy.

● From a short-term investment perspective, the company presents a deteriorated fundamental situation


Strengths

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company does not generate enough profits, which is an alarming weak point.

● The company is in debt and has limited leeway for investment

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 98.49 times its estimated earnings per share for the ongoing year.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the past year, analysts have significantly revised downwards their profit estimates.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● Most analysts recommend that the stock should be sold or reduced.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.